The results of this article provide an innovative direction to develop new drugs for curing gastric cancer. That means drugs able to restore GJIC in cells with deficient gap junction may be used in the prevention and/or treatment of human gastric cancer.
'/>"/>
| Contact: You-De Chang y.d.chang@wjgnet.com 0086-108-538-1892 World Journal of Gastroenterology Source:Eurekalert |